Those looking for a simpler, single-compound precursor approach may prefer NAC
i.e., insulins and analogues, biguanides, sulfonylureas, alpha-glucosidase inhibitors, thiazolidinediones, DPP-4is, GLP-1 RAs, sodium-glucose co-transporter 2 inhibitors, and repaglinide
Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation
Serious safety concerns are rare but include: Systemic infections : Immunocompromised individuals, those with central venous catheters, or patients with damaged gut barriers face increased risk of bacteremia or fungemia from probiotic organisms [19] [20] Antibiotic resistance transfer : Some probiotic strains may carry antibiotic resistance genes Metabolic complications : Rare cases of D-lactic acidosis have been reported with high-dose probiotic use [25] Specific populations requiring caution include patients with severe acute pancreatitis (based on the PROPATRIA trial showing increased mortality), short bowel syndrome, immunosuppression (HIV/AIDS, chemotherapy, organ transplant recipients), and critically ill individuals
& Holmgren, A
